 |
 |
Important Notice: The Forum does not endorse any medical
product or therapy. ALL medications and supplements
should be taken ONLY under the supervision of a physician,
due to the possibility of side-effects, drug interactions,
etc.
|
Animal Model:
|
Prefrontal Cortical Lesion
|
|
Preparation Type:
|
Genetic Preparations
|
|
DA-related behavior:
|
Lesion potentiation of amphetamine induced locomotion under
high stress conditions only
|
|
Gating:
|
Medial lesions only augment PPI and lesions have no effect on LI
|
|
Citations:
|
Miner LA, Ostrander M, Sarter M. Effects of ibotenic
acid-induced loss of neurons in the medial prefrontal cortex
of rats on behavioral vigilance: evidence for executive
dysfunction. J Psychopharmacol . 1997 Jan 1 ; 11(2):169-78.
Abstract
Wilkinson LS, Dias R, Thomas KL, Augood SJ, Everitt
BJ, Robbins TW, Roberts AC. Contrasting effects of
excitotoxic lesions of the prefrontal cortex on the
behavioural response to D-amphetamine and presynaptic and
postsynaptic measures of striatal dopamine function in
monkeys. Neuroscience . 1997 Oct 1 ; 80(3):717-30. Abstract
Lipska BK, Al-Amin HA, Weinberger DR. Excitotoxic
lesions of the rat medial prefrontal cortex. Effects on
abnormal behaviors associated with neonatal hippocampal
damage. Neuropsychopharmacology . 1998 Dec 1 ; 19(6):451-64.
Abstract
Lacroix L, Spinelli S, White W, Feldon J. The
effects of ibotenic acid lesions of the medial and lateral
prefrontal cortex on latent inhibition, prepulse inhibition
and amphetamine-induced hyperlocomotion. Neuroscience . 2000
Jan 1 ; 97(3):459-68. Abstract
|
|
|
 |
|
 |